chr17-50189871-G-A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_000088.4(COL1A1):c.2601C>T(p.Ser867Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,607,358 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.000040   (  0   hom.,  cov: 32) 
 Exomes 𝑓:  0.0000082   (  0   hom.  ) 
Consequence
 COL1A1
NM_000088.4 synonymous
NM_000088.4 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.741  
Publications
1 publications found 
Genes affected
 COL1A1  (HGNC:2197):  (collagen type I alpha 1 chain) This gene encodes the pro-alpha1 chains of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIA, Ehlers-Danlos syndrome Classical type, Caffey Disease and idiopathic osteoporosis. Reciprocal translocations between chromosomes 17 and 22, where this gene and the gene for platelet-derived growth factor beta are located, are associated with a particular type of skin tumor called dermatofibrosarcoma protuberans, resulting from unregulated expression of the growth factor. Two transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008] 
COL1A1 Gene-Disease associations (from GenCC):
- Caffey diseaseInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), G2P, ClinGen
- combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1Inheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Ambry Genetics, ClinGen
- Ehlers-Danlos syndromeInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Ehlers-Danlos syndrome, arthrochalasia typeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen
- osteogenesis imperfecta type 1Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- osteogenesis imperfecta type 2Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- osteogenesis imperfecta type 3Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- osteogenesis imperfecta type 4Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen
- Ehlers-Danlos syndrome, classic type, 1Inheritance: AD Classification: MODERATE Submitted by: ClinGen
- Ehlers-Danlos syndrome, classic typeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Ehlers-Danlos/osteogenesis imperfecta syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- high bone mass osteogenesis imperfectaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47). 
BP6
Variant 17-50189871-G-A is Benign according to our data. Variant chr17-50189871-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 526870.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BP7
Synonymous conserved (PhyloP=-0.741 with no splicing effect.
BS2
High AC in GnomAd4 at 6 AD gene. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| COL1A1 | NM_000088.4 | c.2601C>T | p.Ser867Ser | synonymous_variant | Exon 37 of 51 | ENST00000225964.10 | NP_000079.2 | |
| COL1A1 | XM_011524341.2 | c.2403C>T | p.Ser801Ser | synonymous_variant | Exon 34 of 48 | XP_011522643.1 | ||
| COL1A1 | XM_005257058.5 | c.2601C>T | p.Ser867Ser | synonymous_variant | Exon 37 of 49 | XP_005257115.2 | ||
| COL1A1 | XM_005257059.5 | c.1683C>T | p.Ser561Ser | synonymous_variant | Exon 24 of 38 | XP_005257116.2 | 
Ensembl
Frequencies
GnomAD3 genomes  0.0000397  AC: 6AN: 151114Hom.:  0  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
6
AN: 
151114
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0000168  AC: 4AN: 237946 AF XY:  0.00   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
4
AN: 
237946
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.00000824  AC: 12AN: 1456244Hom.:  0  Cov.: 39 AF XY:  0.00000691  AC XY: 5AN XY: 724010 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
12
AN: 
1456244
Hom.: 
Cov.: 
39
 AF XY: 
AC XY: 
5
AN XY: 
724010
show subpopulations 
African (AFR) 
 AF: 
AC: 
1
AN: 
33380
American (AMR) 
 AF: 
AC: 
3
AN: 
43770
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26032
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39442
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
85694
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
52700
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5752
European-Non Finnish (NFE) 
 AF: 
AC: 
8
AN: 
1109310
Other (OTH) 
 AF: 
AC: 
0
AN: 
60164
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.446 
Heterozygous variant carriers
 0 
 1 
 2 
 4 
 5 
 6 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0000397  AC: 6AN: 151114Hom.:  0  Cov.: 32 AF XY:  0.0000542  AC XY: 4AN XY: 73752 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
6
AN: 
151114
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
4
AN XY: 
73752
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
41062
American (AMR) 
 AF: 
AC: 
6
AN: 
15224
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3462
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5054
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4772
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10556
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
304
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
67708
Other (OTH) 
 AF: 
AC: 
0
AN: 
2074
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.533 
Heterozygous variant carriers
 0 
 1 
 1 
 2 
 2 
 3 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:1 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Osteogenesis imperfecta type I    Benign:1 
Nov 27, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.